Cytokine modulators and related method of use

Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from vaccinium

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S765000, C424S756000, C514S885000

Reexamination Certificate

active

07838050

ABSTRACT:
A composition for modulating cytokines to regulate an inflammatory or immunomodulatory response. The composition can include at least one of rosehips, blueberry, blackberry, elderberry, cranberry, rosemary, clove, feverfew, nettle root, artichoke, reishi mushroom, olive extract, green tea extract, grape seed extract, resveratrol,Aframomum melegueta, boswellia serrataextract,boswellia forte, ipriflavone, tocotrienols, evening primrose oil, INM-176, borage oil, krill oil, at least one type of xanthophyll (e.g., astaxanthin), green coffee extract and ferulic acid. Specifically, a composition of the invention can include: rosehips and at least one of blackberry, blueberry, elderberry, and optionally krill oil; or rosehips, resveratrol and at least one ofAframomum meleguetaand astaxanthin. Based on the cytokine modulation and cytokine response inhibition of the composition, it can be used to regulate an immunomodulatory and/or inflammatory response, and subsequently treat diseases and/or abnormal conditions associated with inflammatory response, for example, cardiovascular conditions, arthritis, osteoporosis and Alzheimer's disease.

REFERENCES:
patent: 74147 (1868-02-01), Rosbrugh
patent: 4110483 (1978-08-01), Bishov
patent: 4839172 (1989-06-01), Morishige
patent: 5165932 (1992-11-01), Horvath
patent: 5466451 (1995-11-01), Beuscher et al.
patent: 5527533 (1996-06-01), Tso et al.
patent: 5540931 (1996-07-01), Hewitt et al.
patent: 5595743 (1997-01-01), Wu
patent: 5683698 (1997-11-01), Chavali et al.
patent: 5714150 (1998-02-01), Nachman
patent: 5854291 (1998-12-01), Laughlin et al.
patent: 5916565 (1999-06-01), Rose et al.
patent: 6022901 (2000-02-01), Goodman
patent: 6024960 (2000-02-01), Kharazmi et al.
patent: 6024998 (2000-02-01), Kreuter et al.
patent: 6103218 (2000-08-01), Brucker et al.
patent: 6146636 (2000-11-01), Breton et al.
patent: 6211247 (2001-04-01), Goodman
patent: 6231866 (2001-05-01), Mann
patent: 6238675 (2001-05-01), Pero
patent: 6264995 (2001-07-01), Newmark et al.
patent: 6274176 (2001-08-01), Tomer et al.
patent: 6333056 (2001-12-01), Robinson
patent: 6344220 (2002-02-01), Rose et al.
patent: 6387416 (2002-05-01), Newmark et al.
patent: 6391310 (2002-05-01), Empie et al.
patent: 6410062 (2002-06-01), Callaghan et al.
patent: 6414037 (2002-07-01), Pezzuto et al.
patent: 6464982 (2002-10-01), Lam
patent: 6468541 (2002-10-01), Lam
patent: 6479080 (2002-11-01), Bombardelli et al.
patent: 6482432 (2002-11-01), Wang
patent: 6485752 (2002-11-01), Rein
patent: 6492429 (2002-12-01), Graus et al.
patent: 6500450 (2002-12-01), Hendrix
patent: 6572882 (2003-06-01), Vercauteren et al.
patent: 6579543 (2003-06-01), McClung
patent: 6582736 (2003-06-01), Quezada
patent: 6586020 (2003-07-01), Breton et al.
patent: 6605296 (2003-08-01), Stuckler
patent: 6638542 (2003-10-01), Nieuwenhuizen et al.
patent: 6638545 (2003-10-01), Rombi
patent: 6642277 (2003-11-01), Howard et al.
patent: 6656925 (2003-12-01), Petrus
patent: 6716883 (2004-04-01), Casper et al.
patent: 6753019 (2004-06-01), Lang et al.
patent: 2001/0012525 (2001-08-01), Mann
patent: 2001/0021400 (2001-09-01), Bombardelli et al.
patent: 2001/0039296 (2001-11-01), Bagchi et al.
patent: 2001/0044411 (2001-11-01), Gelber et al.
patent: 2001/0056071 (2001-12-01), Pelliccia et al.
patent: 2002/0004077 (2002-01-01), Cuomo et al.
patent: 2002/0054924 (2002-05-01), Leahy et al.
patent: 2002/0064568 (2002-05-01), Rose et al.
patent: 2002/0102315 (2002-08-01), Leko
patent: 2002/0119173 (2002-08-01), Lin et al.
patent: 2002/0119952 (2002-08-01), Petrus
patent: 2002/0127243 (2002-09-01), Sun
patent: 2002/0136788 (2002-09-01), Quezada
patent: 2002/0141987 (2002-10-01), Bjarnason
patent: 2002/0146472 (2002-10-01), Chen et al.
patent: 2002/0168429 (2002-11-01), Mann
patent: 2002/0168430 (2002-11-01), Heeg et al.
patent: 2002/0173472 (2002-11-01), Pezzuto et al.
patent: 2002/0182260 (2002-12-01), Mak et al.
patent: 2003/0017217 (2003-01-01), Quintanilla Almagro
patent: 2003/0044474 (2003-03-01), Tao et al.
patent: 2003/0049335 (2003-03-01), Stier et al.
patent: 2003/0077343 (2003-04-01), Martin et al.
patent: 2003/0078304 (2003-04-01), Andersson et al.
patent: 2003/0086986 (2003-05-01), Bruijn et al.
patent: 2003/0108627 (2003-06-01), Selzer et al.
patent: 2003/0139350 (2003-07-01), Larsen et al.
patent: 2003/0143292 (2003-07-01), Cho
patent: 2003/0161897 (2003-08-01), Shanbrom
patent: 2003/0165589 (2003-09-01), Cals-Grieson
patent: 2003/0190381 (2003-10-01), Bland et al.
patent: 2003/0194456 (2003-10-01), Arora et al.
patent: 2003/0203054 (2003-10-01), Selzer et al.
patent: 2004/0014721 (2004-01-01), Hensley et al.
patent: 2004/0022818 (2004-02-01), Cho et al.
patent: 2004/0037903 (2004-02-01), Lemmo et al.
patent: 2004/0086579 (2004-05-01), Higgins et al.
patent: 2004/0109905 (2004-06-01), Bagchi
patent: 2004/0121024 (2004-06-01), Gorsek
patent: 2004/0151761 (2004-08-01), Chew et al.
patent: 2004/0162338 (2004-08-01), Schmitz
patent: 2004/0247706 (2004-12-01), Roberts
patent: 2005/0031573 (2005-02-01), Cho et al.
patent: 2005/0037095 (2005-02-01), Bailey et al.
patent: 2005/0058728 (2005-03-01), Randolph et al.
patent: 2245123 (1999-03-01), None
patent: 2339221 (2000-12-01), None
patent: 2473698 (2003-07-01), None
patent: 101 53 949 (2002-08-01), None
patent: 64860 (1994-03-01), None
patent: 65923 (1994-07-01), None
patent: 7099924 (1995-04-01), None
patent: 7300421 (1995-11-01), None
patent: 2053265 (1996-01-01), None
patent: 1697820 (1991-12-01), None
patent: WO 98/37874 (1998-09-01), None
patent: WO 98/45241 (1998-10-01), None
patent: WO 99/11251 (1999-03-01), None
patent: WO 99/53934 (1999-10-01), None
patent: WO 99/59561 (1999-11-01), None
patent: WO 01/95727 (2001-12-01), None
patent: WO 2005/025586 (2005-03-01), None
patent: WO 2005/027716 (2005-03-01), None
patent: WO 2005/112965 (2005-12-01), None
Bertelli, A. A. et al. International J of Immunotherapy, 2002; 18(3-4): 83-86. Resveratrol prevents interleukin release from isolated monocytes.
Umukoro, S. et al. Nig. Ol. J. Hosp. Med., 2001; 11(1-4): 33-35. Effects ofAframomum melegutaseed extract on thermal pain and carrageenin-induced oedema.
http://en.wikipedia.org/wiki/Blueberry. “Blueberry”pp. 1-6. Downloaded Jan. 24, 2007.
Alternative Medicine Review (2005); 10(1): 51-55. Monograph:Sambucus nigra(Elderberrry).
Bertelli, A. A. et al. International J of Immunotherapy, 2002; 18(3-4): 83-86. Resveratrol prevents interleukin release from isolated monocytes.
Tallarida, RJ. British Journal of Pharmacology (2002); 135: 1589-1590. Commentary on neostigmine interation with non steroidal anti-inflammatory drugs by Miranda et al.
Marquina, M et al. Fitoperia (2002). 73(7-8): 727-729. Hyaluronidase inhibitory activity from the fruit of blueberry (Rubus fruticosusB.).
Schulze-Tanzil, G., et al, Effects of the antirheumatic remedy hox alpha—a new stinging nettle leaf extract—on matrix metalloproteinases in human chondrocytes in vitro, Histol Histopathol. Apr. 2002; 17(2); 477-85 (abstract only).
Piela-Smith TH, et al, Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts, Cell Immunol., May 1, 2001; 209(2); 89-96 (abstract only).
Yesilada, E., et al, Inhibitory effects of Turkish folk remedies on inflammatory cytokines: interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha, J. Ethnopharmacol, Sep. 1997; 58(1); 59-73 (abstract only).
Hwang, D., et al, Inhibition of the expression of inducible cyclooxygenase and proinflammatory cytokines by sesquiterpene lactones in macrophages correlates with the inhibition of MAP kinases, Biochem Biophys Res Commun, Sep 24, 1996; 226(3); 810-8 (abstract only).
Teucher, T., et al, Cytokine secretion in whole blood of healthy subjects following oral administration ofUrtica dioicaL. plant extract, Arzneimittelforschung, Sep. 1996; 46(9); 906-10 (abstract only).
Le Moal, MA, et al, Urtica dioica agglutinin, a new mitogen for murine T lymphocytes: unaltered interleukin-1 production but late interleukin 2-mediated proliferat

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Cytokine modulators and related method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cytokine modulators and related method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine modulators and related method of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4240143

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.